| Discriminatory ability of next-generation tau PET tracers for Alzheimer’s disease SY Yap, B Frias, MC Wren, M Schöll, NC Fox, E Årstad, T Lashley, ... Brain 144 (8), 2284-2290, 2021 | 41 | 2021 |
| Selective radiolabelling with 68 Ga under mild conditions: a route towards a porphyrin PET/PDT theranostic agent SY Yap, TW Price, H Savoie, RW Boyle, GJ Stasiuk Chemical Communications 54 (57), 7952-7954, 2018 | 27 | 2018 |
| Evaluation of a bispidine‐based chelator for gallium‐68 and of the porphyrin conjugate as PET/PDT theranostic agent TW Price, SY Yap, R Gillet, H Savoie, LJ Charbonnière, RW Boyle, ... Chemistry–A European Journal 26 (34), 7602-7608, 2020 | 17 | 2020 |
| Synthesis of a porphyrin with histidine-like chelate: an efficient path towards molecular PDT/SPECT theranostics SY Yap, H Savoie, I Renard, BP Burke, HC Sample, S Michue-Seijas, ... Chemical Communications 56 (75), 11090-11093, 2020 | 11 | 2020 |
| Unearthing the unique stability of thiophosphonium-C-terminal cysteine adducts on peptides and proteins RJ Spears, A Chrzastek, SY Yap, K Karu, AE Aliev, JR Baker, ... Chemical Communications 58 (35), 5359-5362, 2022 | 4 | 2022 |
| Theranostic porphyrin conjugates for the combined treatment and diagnosis of cancer SYY Yap University of Hull, 2019 | | 2019 |
